These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8319445)

  • 21. [Aging and cardiology; various physiological, pathophysiological and clinical aspects].
    Tukkie R; Düren DR; van den Brink RB; Lie KI
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2163-6. PubMed ID: 9550797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Heart failure with conserved systolic function. Therapeutic potential with beta blocking agents].
    Faggiano P; Rusconi C
    Ital Heart J Suppl; 2000 Aug; 1(8):1019-26. PubMed ID: 10993008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart failure in patients with chronic kidney disease.
    Lisowska A; Musiał WJ
    Rocz Akad Med Bialymst; 2004; 49():162-5. PubMed ID: 15631334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
    Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K
    Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of systolic blood pressure in determining risk for cardiovascular disease.
    Levy D
    J Hypertens Suppl; 1999 Feb; 17(1):S15-8. PubMed ID: 10340839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart failure due to diastolic dysfunction: the treatment principles].
    Pinamonti B; di Lenarda A; Sinagra G
    Ital Heart J Suppl; 2000 Apr; 1(4):469-80. PubMed ID: 10832133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future strategies for the treatment of diastolic heart failure.
    Feld Y; Dubi S; Reisner Y; Schwammenthal E; Elami A
    Acute Card Care; 2006; 8(1):13-20. PubMed ID: 16720422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure: management of patients with left-ventricular systolic dysfunction.
    Clin Pract Guidel Quick Ref Guide Clin; 1994 Jun; (11):1-21. PubMed ID: 10892351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Systolic heart failure in the elderly].
    Kilter H; Böhm M
    Dtsch Med Wochenschr; 2005 Mar; 130(12):698-703. PubMed ID: 15776354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of chronic congestive heart failure: Part I--General introduction to treatment.
    Kayser SR
    Prog Cardiovasc Nurs; 1994; 9(1):39-42. PubMed ID: 8058693
    [No Abstract]   [Full Text] [Related]  

  • 33. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Congestive heart failure.
    Vine DL
    Am Fam Physician; 1990 Sep; 42(3):739-52. PubMed ID: 2203240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congestive heart failure--an overview.
    Hegde BM
    J Assoc Physicians India; 1993 Jun; 41(6):379-80. PubMed ID: 8005979
    [No Abstract]   [Full Text] [Related]  

  • 36. Principles of drug therapy in heart failure.
    Dey SK; Poflee VW
    Natl Med J India; 1995; 8(2):73-8. PubMed ID: 7735067
    [No Abstract]   [Full Text] [Related]  

  • 37. [Special aspects of cardiovascular therapy within the scope of emergency medicine].
    Pop T
    Klin Anasthesiol Intensivther; 1995; 47():154-60. PubMed ID: 7715172
    [No Abstract]   [Full Text] [Related]  

  • 38. Heart "timing" versus artery "timing". Neurovegetative effects in compensated and decompensated cardiocirculatory failure.
    Dambrosio M; Federici A
    Funct Neurol; 1991; 6(3):249-53. PubMed ID: 1743537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of septic cardiovascular failure].
    Reinelt H; Lindner KH
    Klin Anasthesiol Intensivther; 1995; 47():139-53. PubMed ID: 7715171
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy of nonseptic cardiogenic circulatory failure].
    Griebenow R
    Klin Anasthesiol Intensivther; 1995; 47():122-8. PubMed ID: 7715169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.